186 related articles for article (PubMed ID: 10366463)
61. Differential expression of matrix metalloproteinase (MMP)-2, MMP-9, and membrane type 1-MMP in hepatocellular and pancreatic adenocarcinoma: implications for tumor progression and clinical prognosis.
Määttä M; Soini Y; Liakka A; Autio-Harmainen H
Clin Cancer Res; 2000 Jul; 6(7):2726-34. PubMed ID: 10914717
[TBL] [Abstract][Full Text] [Related]
62. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
Ries C; Loher F; Zang C; Ismair MG; Petrides PE
Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
[TBL] [Abstract][Full Text] [Related]
63. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
Hu XX; Li L; Li DR; Zhang W; Cheng XQ; Zhang JQ; Tang BJ
Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934
[TBL] [Abstract][Full Text] [Related]
64. Membrane-type matrix metalloproteinase-1(MT1-MTP) gene is overexpressed in highly invasive hepatocellular carcinomas.
Harada T; Arii S; Mise M; Imamura T; Higashitsuji H; Furutani M; Niwano M; Ishigami S; Fukumoto M; Seiki M; Sato H; Imamura M
J Hepatol; 1998 Feb; 28(2):231-9. PubMed ID: 9514536
[TBL] [Abstract][Full Text] [Related]
65. Expression of membrane-type-1-matrix metalloproteinase and metalloproteinase-2 in nonsmall cell lung carcinomas.
Yamamura T; Nakanishi K; Hiroi S; Kumaki F; Sato H; Aida S; Kawai T
Lung Cancer; 2002 Mar; 35(3):249-55. PubMed ID: 11844598
[TBL] [Abstract][Full Text] [Related]
66. Membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation in primary human ovarian epithelial carcinoma cells.
Fishman DA; Bafetti LM; Stack MS
Invasion Metastasis; 1996; 16(3):150-9. PubMed ID: 9186550
[TBL] [Abstract][Full Text] [Related]
67. Prognostic significance of stromal metalloproteinase-2 in ovarian adenocarcinoma and its relation to carcinoma progression.
Torng PL; Mao TL; Chan WY; Huang SC; Lin CT
Gynecol Oncol; 2004 Feb; 92(2):559-67. PubMed ID: 14766248
[TBL] [Abstract][Full Text] [Related]
68. Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in non-small-cell lung cancer.
Suzuki M; Iizasa T; Fujisawa T; Baba M; Yamaguchi Y; Kimura H; Suzuki H
Invasion Metastasis; 1998-1999; 18(3):134-41. PubMed ID: 10474026
[TBL] [Abstract][Full Text] [Related]
69. Analysis of expression of matrix metalloproteinases-2 and -9 in hypopharyngeal squamous cell carcinoma by in situ hybridization.
Miyajima Y; Nakano R; Morimatsu M
Ann Otol Rhinol Laryngol; 1995 Sep; 104(9 Pt 1):678-84. PubMed ID: 7661515
[TBL] [Abstract][Full Text] [Related]
70. Rapid trafficking of membrane type 1-matrix metalloproteinase to the cell surface regulates progelatinase a activation.
Zucker S; Hymowitz M; Conner CE; DiYanni EA; Cao J
Lab Invest; 2002 Dec; 82(12):1673-84. PubMed ID: 12480917
[TBL] [Abstract][Full Text] [Related]
71. Augmented membrane type 1 matrix metalloproteinase (MT1-MMP):MMP-2 messenger RNA ratio in gastric carcinomas with poor prognosis.
Caenazzo C; Onisto M; Sartor L; Scalerta R; Giraldo A; Nitti D; Garbisa S
Clin Cancer Res; 1998 Sep; 4(9):2179-86. PubMed ID: 9748137
[TBL] [Abstract][Full Text] [Related]
72. Membrane type 1 matrix metalloproteinase expression in human atherosclerotic plaques: evidence for activation by proinflammatory mediators.
Rajavashisth TB; Xu XP; Jovinge S; Meisel S; Xu XO; Chai NN; Fishbein MC; Kaul S; Cercek B; Sharifi B; Shah PK
Circulation; 1999 Jun; 99(24):3103-9. PubMed ID: 10377072
[TBL] [Abstract][Full Text] [Related]
73. Tumor progression and expression of matrix metalloproteinase-2 (MMP-2) mRNA by human urinary bladder cancer cells.
Hamasaki T; Hattori T; Kimura G; Nakazawa N
Urol Res; 1998; 26(6):371-6. PubMed ID: 9879815
[TBL] [Abstract][Full Text] [Related]
74. Expression and prognostic significance of metalloproteinases and their tissue inhibitors in patients with small-cell lung cancer.
Michael M; Babic B; Khokha R; Tsao M; Ho J; Pintilie M; Leco K; Chamberlain D; Shepherd FA
J Clin Oncol; 1999 Jun; 17(6):1802-8. PubMed ID: 10561218
[TBL] [Abstract][Full Text] [Related]
75. Calcium regulation of matrix metalloproteinase-mediated migration in oral squamous cell carcinoma cells.
Munshi HG; Wu YI; Ariztia EV; Stack MS
J Biol Chem; 2002 Nov; 277(44):41480-8. PubMed ID: 12194986
[TBL] [Abstract][Full Text] [Related]
76. New collagenolytic enzymes/cascade identified at the pannus-hard tissue junction in rheumatoid arthritis: destruction from above.
Konttinen YT; Ceponis A; Takagi M; Ainola M; Sorsa T; Sutinen M; Salo T; Ma J; Santavirta S; Seiki M
Matrix Biol; 1998 Dec; 17(8-9):585-601. PubMed ID: 9923652
[TBL] [Abstract][Full Text] [Related]
77. Enhanced expression of tissue inhibitors of metalloproteinases in human colorectal tumors.
Murashige M; Miyahara M; Shiraishi N; Saito T; Kohno K; Kobayashi M
Jpn J Clin Oncol; 1996 Oct; 26(5):303-9. PubMed ID: 8895669
[TBL] [Abstract][Full Text] [Related]
78. In situ localization and quantification of seventy-two-kilodalton type IV collagenase in aneurysmal, occlusive, and normal aorta.
McMillan WD; Patterson BK; Keen RR; Pearce WH
J Vasc Surg; 1995 Sep; 22(3):295-305. PubMed ID: 7674473
[TBL] [Abstract][Full Text] [Related]
79. Expression of matrix metalloproteinase-2 (MMP-2) and of membrane-type-1-matrix metalloproteinase (MT1-MMP) in transitional cell carcinoma of the upper urinary tract.
Nakanishi K; Kawai T; Sato H; Aida S; Kasamatsu H; Aurues T; Ikeda T
Hum Pathol; 2000 Feb; 31(2):193-200. PubMed ID: 10685633
[TBL] [Abstract][Full Text] [Related]
80. TIMP-2 (tissue inhibitor of metalloproteinase-2) regulates MMP-2 (matrix metalloproteinase-2) activity in the extracellular environment after pro-MMP-2 activation by MT1 (membrane type 1)-MMP.
Bernardo MM; Fridman R
Biochem J; 2003 Sep; 374(Pt 3):739-45. PubMed ID: 12755684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
